Christian Hassig's most recent trade in Boundless Bio Inc. was a trade of 95,000 Stock Option done . Disclosure was reported to the exchange on Jan. 22, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 95,000 | 95,000 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 94,871 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 76,173 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 76,173 | 76,173 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 62,820 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 62,820 | 62,820 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 48,703 | 48,703 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 48,703 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 10,256 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,256 | 10,256 | - | - | Stock Option | |
Boundless Bio Inc. | Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 48,703 | 48,703 | - | - | Stock Option |